|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,192.00 INR | -0.59% |
|
-1.95% | +7.70% |
| 22/07 | Shares in Generic-Drug Makers Fall After Trump's Tariff Plan -- Update | DJ |
| 22/07 | Shares in Generic-Drug Makers Fall After Trump's Tariff Plan | DJ |
| Market Cap | 62TCr 642.34Cr 564.17Cr 524.67Cr 481.45Cr 904.61Cr 918.55Cr 6.23TCr 2.43TCr 30TCr 2.41TCr 2.36TCr 1,05100Cr | P/E 2026 |
44.2x | P/E 2027 * | 26.3x |
|---|---|---|---|---|---|
| Enterprise Value | 58TCr 601.54Cr 528.33Cr 491.34Cr 450.87Cr 847.14Cr 860.2Cr 5.83TCr 2.28TCr 28TCr 2.26TCr 2.21TCr 98TCr | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.49x |
| Free-Float |
51.03% | Yield 2026 |
0.12% | Yield 2027 * | 0.24% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | -0.59% | ||
| 1 week | -1.95% | ||
| Current month | -0.56% | ||
| 1 month | +1.75% | ||
| 3 months | -4.67% | ||
| 6 months | +11.40% | ||
| Current year | +7.70% |
| 1 week | 2,166 |  | 2,270 |
| 1 month | 2,142.8 | | 2,326.1 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 85 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.59% | -1.95% | +2.18% | +179.57% | 642.34Cr | |
| -0.66% | +0.44% | +14.25% | +77.26% | 4.84TCr | |
| +2.20% | +1.41% | +57.98% | +112.68% | 3.58TCr | |
| +1.26% | -0.57% | -7.95% | +33.74% | 1.18TCr | |
| -0.46% | -3.06% | +13.55% | +78.32% | 1.15TCr | |
| -0.37% | -0.37% | +37.53% | +140.99% | 901.45Cr | |
| +1.52% | +0.39% | +49.34% | -7.78% | 698.99Cr | |
| -0.17% | -2.92% | +11.72% | +32.23% | 669.73Cr | |
| -7.92% | -13.61% | -33.87% | -3.07% | 529.99Cr | |
| -2.05% | -1.46% | +21.02% | +122.89% | 436.97Cr | |
| Average | -0.72% | -2.05% | +16.57% | +76.68% | 1.46TCr | |
| Weighted average by Cap. | +0.05% | -0.48% | +24.03% | +83.24% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 15TCr 158.99Cr 139.64Cr 129.87Cr 119.17Cr 223.91Cr 227.36Cr 1.54TCr 602.49Cr 7.53TCr 596.86Cr 584Cr 26TCr | 17TCr 173.12Cr 152.05Cr 141.41Cr 129.76Cr 243.81Cr 247.56Cr 1.68TCr 656.03Cr 8.2TCr 649.9Cr 635.9Cr 28TCr |
| Net income | 2.05TCr 21Cr 19Cr 17Cr 16Cr 30Cr 30Cr 206.79Cr 81Cr 1.01TCr 80Cr 78Cr 3.49TCr | 2.33TCr 24Cr 21Cr 20Cr 18Cr 34Cr 35Cr 234.5Cr 92Cr 1.14TCr 91Cr 89Cr 3.96TCr |
| Net Debt | -3.93TCr -41Cr -36Cr -33Cr -31Cr -57Cr -58Cr -395.76Cr -154.62Cr -1.93TCr -153.18Cr -149.87Cr -6.68TCr | -3.71TCr -39Cr -34Cr -31Cr -29Cr -54Cr -55Cr -373.89Cr -146.07Cr -1.83TCr -144.71Cr -141.59Cr -6.31TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | ₹2,192.00 | -0.59% | 4,29,562 |
| 23/26/23 | ₹2,205.10 | +0.24% | 5,67,718 |
| 22/26/22 | ₹2,199.90 | -1.88% | 9,42,175 |
| 21/26/21 | ₹2,242.10 | +0.12% | 2,74,753 |
| 20/26/20 | ₹2,239.50 | +0.18% | 9,14,679 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
